Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, September 10, 2015
Frontage, a full service contract research organization (CRO), has announced the appointment of Michael S. Willett, PharmD., RAC as President of its clinical business unit.
read more
Frontage Laboratories announces the acquisition of Concord Biosciences, formerly known as Ricerca Biosciences, a preclinical CRO located near Cleveland, Ohio.
read more
Freyr has announced the launch of a web platform for Covid-19 driven with real-time information for manufacturers.
read more
Fresenius has decided today to terminate the company’s merger agreement with Akorn, due to Akorn’s failure to fulfill several closing conditions.
read more
Fresenius Medical Care and Humacyte announced a strategic, global partnership and a $150M USD equity investment.
read more
Fresenius Medical Care North America's Renal Therapies Group is preparing its first shipment of multiBic dialysate solutions for use in continuous renal replacement therapy.
read more
Tuesday, November 21, 2017
Fresenius Kabi will expand its manufacturing operations in Wilson County, Governor Roy Cooper announced.
read more
Kabi, a leading provider of infusion therapy and clinical nutrition, and Fenwal Inc. a global leader specializing in separation technologies for blood and cell collection and therapy, announced today a definitive agreement for Fresenius Kabi to ...
read more
Wednesday, April 26, 2017
Fresenius Kabi will acquire Akorn, a U.S.-based manufacturer and marketer of prescription and over-the-counter pharmaceutical products, for approximately $4.3 billion, or $34.00 a share, plus the assumption of approximately $450 million of debt.
read more
Monday, December 03, 2018
Fresenius Kabi has received a Drug Shortage Assistance Award from the U.S. Food and Drug Administration (FDA).
read more
Fresenius Kabi USA is voluntarily recalling two lots of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection, 200 mcg/50 mL (4 mcg / mL), 50 mL fill in a 50 mL vial.
read more
Monday, December 07, 2020
Fresenius Kabi USA is voluntarily recalling a single lot of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection, 200 mcg/50 mL (4 mcg /mL), 50 mL fill in a 50 mL vial.
read more
Fresenius Kabi is voluntarily recalling two lots of Fluorouracil Injection, USP 5g/100mL (50mg/mL), 100mL fill in 100mL vials, to the user level due to the potential for glass particulate.
read more
Wednesday, October 06, 2021
Fresenius Kabi and Health Care Logistics®, Inc. (HCL) today announced a collaboration designed to make drug replenishment in hospitals more efficient and improve patient safety throughout the medication-use process. The new collaboration allows ...
read more
Frenova Renal Research announced that its F1RST Up alliance of clinical research sites focusing on kidney disease has expanded to include 55 physician investigators representing 23 sites.
read more